GSA CAPITAL PARTNERS LLP - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 168 filers reported holding ACCELERON PHARMA INC in Q2 2019. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q1 2021$1,159,000
+63.7%
8,543
-36.0%
0.19%
+134.1%
Q4 2019$708,000
+198.7%
13,357
+162.7%
0.08%
+241.7%
Q1 2019$237,000
-84.2%
5,085
-87.3%
0.02%
-76.5%
Q3 2017$1,496,000
-33.1%
40,099
-52.5%
0.10%
-15.0%
Q1 2017$2,237,00084,5000.12%
Other shareholders
ACCELERON PHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
Polaris Venture Management Co IV LLC 2,803,645$84,782,00078.57%
Cormorant Asset Management, LP 400,000$12,096,0002.49%
Deer VII & Co. Ltd. 175,075$5,294,0002.36%
QVT Financial LP 1,193,258$36,084,0001.86%
Foresite Capital Management I, LLC 55,767$1,686,0001.62%
Perceptive Advisors 445,000$13,457,0001.44%
SECTORAL ASSET MANAGEMENT INC 726,424$21,967,0000.92%
Iguana Healthcare Management, LLC 25,000$756,0000.40%
SPHERA FUNDS MANAGEMENT LTD. 100,000$3,024,0000.37%
Eventide Asset Management 62,100$1,878,0000.26%
View complete list of ACCELERON PHARMA INC shareholders